Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata causes hair loss, has no cure, and various treatments exist.

Low doses of some substances can be beneficial, while high doses can be harmful or toxic.

The telogen phase of hair growth is active and important for preparing hair follicles for regeneration, not just a resting stage.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Hair follicles are hormone-sensitive and involved in growth and other functions, with potential for new treatments, but more research is needed.

Minoxidil and finasteride are effective for male hair loss, minoxidil for female hair loss, and various treatments like corticosteroids work for alopecia areata; treatment should be tailored to the individual.

Minoxidil and finasteride treat hair loss; more research needed for other options.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Brain hormones significantly affect hair color and could potentially be used to prevent or reverse grey hair.

The document concludes that mouse models are crucial for studying hair biology and that all mutant mice may have hair growth abnormalities that require detailed analysis to identify.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Shift nurses show altered body temperature and stress hormone levels, suggesting their body clocks adjust to irregular schedules.

The document concludes that more research is needed to understand how to treat muscle pain with drugs.

The study suggests that motor neurons created from stem cells of patients with spinal and bulbar muscular atrophy show signs of the disease, including changes in protein levels and cell functions.

Some treatments can help with hair regrowth in alopecia areata, but results vary and long-term use is often needed without changing the disease's outcome.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

TGF-β2 plays a key role in human hair growth and development.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

Adrenal gland disease is common in ferrets and causes hair loss and other symptoms.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

Some anticonvulsant drugs can cause skin reactions, ranging from mild to severe, and managing these reactions is important for patient care.

A yeast-based test can detect the steroid methyltestosterone in urine longer than traditional methods.

Some oral medications may help treat central serous chorioretinopathy, especially eplerenone, but more research is needed.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.